openPR Logo
Press release

PHARMACEUTICAL EXCIPIENTS MARKET TO SURPASS US$ 9.8 BILLION BY 2024 : CMI

02-27-2017 07:03 PM CET | Health & Medicine

Press release from: PHARMACEUTICAL EXCIPIENTS MARKET

PHARMACEUTICAL EXCIPIENTS MARKET TO SURPASS US$ 9.8 BILLION

The Global Pharmaceutical Excipients Market was valued at US$ 5,394.2 million in 2015 and is projected to expand at a CAGR of 6.9% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Rise in demand for oral pharmaceutical products globally in the form of solid as well as liquid dosage forms, in turn is expected to underpin growth of the pharmaceutical excipients market in the near future.

Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/124

Excipients plays a vital part in drug dosage formulation as they are mixed with active pharmaceutical ingredients that forms the volume for any pharmaceutical product. Pharmaceutical excipients possess various properties that are utilized by API for making bulk of any product and can also improve drugs bioavailability in certain cases. Though there are various types of pharmaceutical excipients, only particular excipients are most compatible for a specific dosage form. Pharmaceutical excipients do not have same properties as API, though they need to be stabilized and standardized before use. In 2016, according to an update from William Reed Business Media Ltd., the IPEC association of China was included as the fifth member of global excipient certification organization. This inclusion is expected to favor the promotion of safety regarding excipients throughout the supply chain in China.

New product development incurs a significant amount of effort and time along with high cost expenditure. However, product development in pharmaceutical excipients is economical as compared to drug or API development. Quality by design is a scientific method that also involves risk-based approach at product concept stage. In 2002, the U.S. Food and Drug Administration (FDA) started an initiative for pharmaceutical companies called pharmaceutical current good manufacturing Practices (GMP). This was considered to be a risk-based approach that encouraged various organizations involved in pharmaceutical product manufacturing to adopt management techniques to enhance quality in keeping with modern standards. Furthermore, companies are now focused towards expanding their geographical reach by setting up new plants and manufacturing units worldwide based on the potential of the region. For instance, in 2016, according to William Reed Business Media Ltd update, Ashland Inc., established a new pharmaceutical excipients manufacturing unit in Nanjing, China, in order to cater to rise in local demand and new quality regulations. This would provide a major stronghold for the company in the region.

The market for pharmaceutical excipients is expected to grow significantly over the forecast period. Since pharmaceutical excipients play an important role in the finished pharmaceutical products, varying pharmaceutical products require different forms of excipients. According to Saffron Media Pvt. Ltd, in 2014, there were around 1,200 excipients available in the market that were used in the pharmaceutical industry for product development. However, there is still need for more variations in the properties of excipients to meet emerging needs. This can be achieved by using multifunctional excipients that include preprocessed and co-processed pharmaceutical ingredients. Biopharmaceutical companies are also inclined towards use of excipients for enhancing the stability and add bulk to biologics.

Key takeaways of the market:

The global pharmaceutical excipients market is expected to expand at a CAGR of 6.9% during the forecast period (2016–2024). The rise in market for oral formulation is expected to favor the market for pharmaceutical excipients over the forecast period. This has been supported by the introduction of different types of oral dosage for having variations in release timing and coating properties.

The binder functionality type segment in the global pharmaceutical excipients market was estimated to be the largest in 2015 and is expected to dominate the market throughout the forecast period in terms of value. This is expected to grow in the near future on the backdrop of rise in demand for oral dosage forms globally.

In terms of product type, the plant chemistry type segment is expected to expand at a significant CAGR of 7.8% during the forecast period. The growing demand for plant products are projected to favor the market for pharmaceutical excipients market in the near future

To know the latest trends and insights prevalent in the pharmaceutical excipients market, click the link below: https://www.coherentmarketinsights.com/market-insight/pharmaceutical-excipients-market-124

The global pharmaceutical excipients market is characterized by strategic research and development and advancements in the excipients processing, also the organizations involved in the manufacturing of the excipients are now inclined towards product development to expand their product portfolio. For instance, according to pharmaceutical technology, in 2012, Ashland announced the expansion of production of Polyplasdone cross-linked polyvinylpyrrolidone (PVPP) in Texas City manufacturing facility.

Some of the major players are Innophos Holdings Inc., The Dow Chemical Company, The Lubrizol Corporation, Wacker Chemie AG, and Ashland Inc., BASF SE, and Evonik Industries AG

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PHARMACEUTICAL EXCIPIENTS MARKET TO SURPASS US$ 9.8 BILLION BY 2024 : CMI here

News-ID: 449471 • Views: 270

More Releases from PHARMACEUTICAL EXCIPIENTS MARKET

Pharmaceutical Excipients Market to 2017-2021: BASF SE, Evonik Industries AG, In …
Researchmoz added Most up-to-date research on "Global Market Study on Pharmaceutical Excipients: Synthetic Chemistry Type Anticipated to Remain Dominant During 2017-2021" to its huge collection of research reports. This Persistence Market Research report examines the global pharmaceutical excipients market for the period 2017-2021. The primary objective of the report is to offer insights into the developments in the pharmaceutical excipients market that are significantly transforming global businesses and enterprises. To Get
Pharmaceutical Excipients Market is anticipated to reach a valuation of US$ 7,41 …
Microcrystalline cellulose (MCC) is one of the most widely used excipients in Europe and Asia Pacific. The prime reasons contributing to MCC’s popularity is its multi-functionality as a diluent used in direct compression and also that it is an anti-caking agent and an emulsifier. Furthermore, it fulfils all USP standards, which further drives its demand. In addition, manufacture of oral liquid formulations is gaining popularity as a patient-centric drug delivery
Global Pharmaceutical Excipients Market Forecast 2018-2025 : BASF SE, Evonik Ind …
ResearchMoz include new market research report "Global Market Study on Pharmaceutical Excipients: Synthetic Chemistry Type Anticipated to Remain Dominant During 2017-2021" to its huge collection of research reports. The pharmaceutical excipients market report begins with an overview of the pharmaceutical excipients process and analysis about why excipients are needed in the manufacturing of drugs. This section includes identifying the key functions of excipients and the respective considerations in each segment for
Pharmaceutical Excipients Market to 2017-2021: BASF SE, Evonik Industries AG, In …
Researchmoz added Most up-to-date research on "Global Market Study on Pharmaceutical Excipients: Synthetic Chemistry Type Anticipated to Remain Dominant During 2017-2021" to its huge collection of research reports. This Persistence Market Research report examines the global pharmaceutical excipients market for the period 2017-2021. The primary objective of the report is to offer insights into the developments in the pharmaceutical excipients market that are significantly transforming global businesses and enterprises. Report Inclusions The

All 5 Releases


More Releases for Coherent

Food Additives Market Segments, Share, Trends 2027 | Coherent Market Insights
The Food Additives report presents high-quality and wide-ranging research study with key factors that are expected to have a Major impact on the Food Additives during the forecast period. The report present Key Market segments valued based on its growth rate and share.This report also provides an analysis of the impact of the COVID-19 pandemic on Industrial Labels Industry.The report explains the historical and current trends that are shaping
Tissue Paper Market Segments, Share, Trends 2027 | Coherent Market Insights
The Tissue Paper Industry market report studies vital factors about the Tissue Paper Industry that are essential to be understood by existing as well as latest market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, key market players, regional segmentation, and many more crucial aspects related to the Global Tissue Paper Industry Market. This Tissue Paper market report aims to provide all the
Thaumatin Market Segments, Share, Trends 2027| Coherent Market Insights
Coherent Market Insights, the fastest growing market research company, released a report on the Thaumatin . This market report offers an overall scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future prospects of the market. The report discusses the competitive data analysis of emerging and leading market players. Further, it offers comprehensive data analysis on risk
Gaffers Tape Market Segments, Share, Trends 2027| Coherent Market Insights
Global Gaffers Tape Market research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Gaffers Tape analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. Results of the recent scientific undertakings towards the development of Gaffers Tape
AI App Development || Coherent Lab LLP
The IT industry is growing day by day and immense popularity. Nowadays, businesses are in search of better opportunities to make money in more innovative way. Considering the AI (artificial intelligence) in mobile and web app development, we at Coherent Lab LLP focuses on developing practical solutions which streamlines to generate more and more profits and smoothen the operations as well. Situated in the heart of pinkcity, Jaipur, Coherent Lab
PHASE-XS – A New Proprietary Database of Coherent Market Insights
PHASE-XS is a database developed by Coherent Market Insights, a market intelligence and consulting company. This database provides clinical information about phase 3 and phase 4 products for biologics and biosimilars. Information related to trial design, current phase, patent expiry, indication, technology, therapeutic category, approved indications, end point analysis, research locations, dosage, physician-administered or self-administered, route of administration, update, reimbursement, addressable patient population, and more of key data is included